|
|
|
|
Celgene shares drop as Baird issues downgrade
NEW YORK (AP) -- Robert W.Baird & Co. analyst Christopher Raymond downgraded shares of Celgene Corp. Tuesday, saying sales of the key revenue driver Revlimid could fall short of expectations in 2009. Raymond cut the rating to ...
|
|
|
Celgene shares slip as Baird issues downgrade
NEW YORK (AP) -- Robert W.Baird & Co. analyst Christopher Raymond downgraded shares of Celgene Corp. Tuesday, saying sales of the key revenue driver Revlimid could fall short of expectations in 2009. Raymond cut the rating to ...
|
|
|
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
- (NewsRx.com) -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research released by Avalere Health and...
|
|
|
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
Latest Health News WASHINGTON, Dec.12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009,...
|
|
|
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
The Avalere-ACS CAN research found that Medicare stand-alone prescription drug plans (PDPs) have been increasingly shifting name-brand oral cancer drugs to higher formulary tiers over the last four years, meaning that with each year, the...
|
|
|
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
WASHINGTON The Avalere-ACS CAN research found that Medicare stand-alone prescription drug plans (PDPs) have been increasingly shifting name-brand oral cancer drugs to higher formulary tiers over the last four years, meaning that with each...
|
|
|
Prescription Drug Benefits For Cancer Medicare Patients To Cost More In 2009
People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research released today by Avalere Health and the American...
|
|
|
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
KSLA Health Connections Health WASHINGTON, Dec.12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in...
|
|
|
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
Latest Health News WASHINGTON, Dec.12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009,...
|
|
|
Prescription Drug Benefits For Medicare Patients With Cancer To Cost More In 2009
People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research released by Avalere Health and the American Cancer...
|
|
|
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
WASHINGTON, Dec.12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research...
|
|
|
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
/PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research released today by...
|
|
|
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
WASHINGTON, Dec.12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research...
|
|
|
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
WASHINGTON, Dec.12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research...
|
|
|
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
WASHINGTON, Dec.12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research...
|
|
|
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
WASHINGTON, Dec.12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research...
|
|
|
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
WASHINGTON, Dec.12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research...
|
|
|
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
WASHINGTON, Dec.12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research...
|
|
|
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
WASHINGTON, Dec.12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research...
|
|
|
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research released today by Avalere Health and the American...
|
|
|
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
WASHINGTON, Dec.12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research...
|
|
|
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
WASHINGTON, Dec.12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research...
|
|
|
Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of Ameri
Paul Richardson presents combined results from a Phase 1/2 study of perifosine in combination with bortezomib (+/- dexamethasone) in multiple myeloma patients relapsed from or refractory to bortezomib NEW YORK, Dec.9 /PRNewswire-FirstCall...
|
|
|
Alzheimer's Drug Discovery Foundation Funds P2D to Develop Anti-Alzheimer's Disease Drug
NEW YORK, NY -- (Marketwire) -- 12/02/08 -- The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it is providing a biotechnology founder's grant of $300,000 to P2D Biosciences (P2D), a start-up biotechnology company...
|
|
|
Alzheimer's Drug Discovery Foundation Funds P2D to Develop Anti-Alzheimer's Disease Drug
NEW YORK, NY, December 2 / MARKET WIRE/ -- The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it is providing a biotechnology founder's grant of $300,000 to P2D Biosciences (P2D), a start-up biotechnology company dedicated...
|
